How little is known about the role of human Foxp3+ Tregs in tumors (original) (raw)
Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions
Jocelyne Demengeot
European Journal of Immunology, 2009
View PDFchevron_right
Stability and Maintenance of Foxp3+ Treg Cells in Non-lymphoid Microenvironments
Thomas Korn
Frontiers in Immunology
View PDFchevron_right
Induction, control, and plasticity of Treg cells: The immune regulatory network revised?
Vincenzo Barnaba
European Journal of Immunology, 2013
View PDFchevron_right
Role of CD4+CD25+FOXP3+ TReg cells on tumor immunity
Soehartati Gondhowiardjo
Immunological Medicine
View PDFchevron_right
Frequency of Circulating Tregs with Demethylated FOXP3 Intron 1 in Melanoma Patients Receiving Tumor Vaccines and Potentially Treg-Depleting Agents
C. Castelli
Clinical Cancer Research, 2011
View PDFchevron_right
Lymph Node Occupancy Is Required for the Peripheral Development of Alloantigen-Specific Foxp3+ Regulatory T Cells
Adam Yopp, Jordi Ochando
The Journal of Immunology, 2005
View PDFchevron_right
The origin of tumour-infiltrating regulatory T cells
João Freitas
2019
View PDFchevron_right
FOXP3+ Tregs and B7-H1+/PD-1+ T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy
Naser Elkum, Said Dermime
BMC Cancer, 2008
View PDFchevron_right
Regulatory T-Cell (Treg) hybridoma as a novel tool to study Foxp3 regulation and Treg fate
rahul sharma
Journal of Autoimmunity, 2011
View PDFchevron_right
Foxp3 Expressing CD4CD25high Regulatory T Cells Are Overrepresented in Human Metastatic Melanoma Lymph Nodes and Inhibit the Function of Infiltrating T Cells1
Guy Gorochov
2000
View PDFchevron_right
Dynamics of peripheral tolerance and immune regulation mediated by Treg
Kajsa Wing
European Journal of Immunology, 2009
View PDFchevron_right
Site-specific anti-tumor immunity: Differences in DC function, TGF-β production and numbers of intratumoral Foxp3+ Treg
Karl Frei
European Journal of Immunology, 2009
View PDFchevron_right
Skin Melanoma Development in ret Transgenic Mice Despite the Depletion of CD25+Foxp3+ Regulatory T Cells in Lymphoid Organs
Christine Falk, S. Kimpfler
The Journal of Immunology, 2009
View PDFchevron_right
The T-cell Receptor Repertoire of Tumor-Infiltrating Regulatory T Lymphocytes Is Skewed Toward Public Sequences
Claude Leclerc
Cancer Research, 2012
View PDFchevron_right
Genetically Induced Tumors in the Oncopig Model Invoke an Antitumor Immune Response Dominated by Cytotoxic CD8β+ T Cells and Differentiated γδ T Cells Alongside a Regulatory Response Mediated by FOXP3+ T Cells and Immunoregulatory Molecules
Laurie Rund
Frontiers in Immunology
View PDFchevron_right
Recruitment and Expansion of Tregs Cells in the Tumor Environment—How to Target Them?
Christine Ménétrier-caux
Cancers
View PDFchevron_right
Contribution of regulatory T cells to cancer: A review
Masoud Najafi
View PDFchevron_right
Intratumoral Convergence of the TCR Repertoires of Effector and Foxp3+ CD4+ T cells
Michal Kuczma
PLoS ONE, 2010
View PDFchevron_right
Reciprocal effects of Th1 and Treg cell inducing pathogen-associated immunomodulatory molecules on anti-tumor immunity
Andrew Jarnicki
Cancer Immunology, Immunotherapy, 2007
View PDFchevron_right
Induction of anergic or regulatory tumor-specific CD4+ T cells in the tumor-draining lymph node
Eliane Piaggio
Nature Communications
View PDFchevron_right
Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase
Madhav Sharma
Journal of Clinical Investigation, 2007
View PDFchevron_right
Regulatory T-cell stability and plasticity in mucosal and systemic immune systems
Mitchell Kronenberg
Mucosal Immunology, 2010
View PDFchevron_right
Peripherally induced tregs - role in immune homeostasis and autoimmunity
mahesh yadav
Frontiers in immunology, 2013
View PDFchevron_right
Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients
Eliane Piaggio
Nature Communications
View PDFchevron_right
Antitumor Immunity Graft-versus-Host Disease and Generation: Implications in Regulatory Lymphocyte + FOXP3
A. Radlovic, Jean-paul Remy-martin
2000
View PDFchevron_right
Treg Depletion Inhibits Efficacy of Cancer Immunotherapy: Implications for Clinical Trials
Pedro Lowenstein
PLoS ONE, 2008
View PDFchevron_right
Treg cells to the rescue
David Fox
Arthritis & Rheumatism, 2012
View PDFchevron_right
Competition for cytokines: Treg cells take all
Alexander Scheffold
Nature Immunology, 2007
View PDFchevron_right
Examining the immune response in sentinel lymph nodes of mice and men
Hong-Ming Hu
European Journal of Nuclear Medicine, 1999
View PDFchevron_right
Tumor-associated Tregs obstruct antitumor immunity by promoting T cell dysfunction and restricting clonal diversity in tumor-infiltrating CD8+ T cells
Saheed Oseni
Journal for ImmunoTherapy of Cancer
View PDFchevron_right
Regulatory lymphocytes: the dice that resolve the tumor endgame
Gaurisankar Sa
Applied Cancer Research, 2020
View PDFchevron_right
Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner
TT ZHANG
Clinical Immunology, 2010
View PDFchevron_right
Tumor Regulatory T Cells Potently Abrogate Antitumor Immunity
Louis Falo
The Journal of Immunology, 2009
View PDFchevron_right
Depletion of tumor-induced Treg prior to reconstitution rescues enhanced priming of tumor-specific, therapeutic effector T cells in lymphopenic hosts
Bernard Fox
European Journal of Immunology, 2009
View PDFchevron_right